Home » Topics » BioWorld Science

BioWorld Science
RSS

Sustained-release preparations of hypoglycemic drugs described by Ajinomoto

Aug. 9, 2001

Trimeris and Array Biopharma sign drug discovery agreement

Aug. 9, 2001

FDA approves PEG-Intron for use with Rebetol

Aug. 9, 2001

Baxter to acquire Asta Medica Oncology

Aug. 9, 2001

Bayer withdraws cerivastatin worldwide

Aug. 9, 2001

Guanfacine improves tic disorders and ADHD in children

Aug. 9, 2001

MedImmune begins Vitaxin phase I trials for rheumatoid arthritis

Aug. 9, 2001

Lorus Therapeutics expands Virulizin clinical trial for pancreatic cancer

Aug. 9, 2001

Novel imino sugar inhibits HBV DNA replication without affecting DNA polymerase function

Aug. 9, 2001

Lexicon Genetics and Immunex enter drug target validation agreement

Aug. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...